<DOC>
	<DOCNO>NCT01767324</DOCNO>
	<brief_summary>The goal exploratory study select optimal body site intracutaneous delivery 0.5 milliliter saline FLUGEN 101.2 microneedle-based device .</brief_summary>
	<brief_title>Site Selection Intracutaneous Saline Delivery</brief_title>
	<detailed_description />
	<criteria>Able read and/or understand sign Informed Consent Form Medical history acute chronic skin disease Active skin allergy acute skin infection , tattoo ( ) , scar , sunburn skin abnormality prospective injection site Hirsute prospective injection site Diabetes High level anxiety depression history psychosis Abuse alcohol use drug abuse include tobacco Pregnant breastfeed woman Any medical condition may interfere study protocol adherence include completion study activity Foreseeable inability complete study schedule .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>microneedle-based array</keyword>
	<keyword>hollow microneedle</keyword>
	<keyword>intracutaneous</keyword>
	<keyword>drug delivery</keyword>
	<keyword>vaccine delivery</keyword>
</DOC>